Dahab MA - Search Results

1

Design, synthesis, docking, MD simulations, and anti-proliferative evaluation of thieno[2,3-d]pyrimidine derivatives as new EGFR inhibitors.

Sobh EA, Dahab MA, Elkaeed EB, Alsfouk AA, Ibrahim IM, Metwaly AM, Eissa IH. Sobh EA, et al. Among authors: dahab ma. J Enzyme Inhib Med Chem. 2023 Dec;38(1):2220579. doi: 10.1080/14756366.2023.2220579. J Enzyme Inhib Med Chem. 2023. PMID: 37288786 Free PMC article.

2

New quinoxaline derivatives as VEGFR-2 inhibitors with anticancer and apoptotic activity: Design, molecular modeling, and synthesis.

Alsaif NA, Dahab MA, Alanazi MM, Obaidullah AJ, Al-Mehizia AA, Alanazi MM, Aldawas S, Mahdy HA, Elkady H. Alsaif NA, et al. Among authors: dahab ma. Bioorg Chem. 2021 May;110:104807. doi: 10.1016/j.bioorg.2021.104807. Epub 2021 Mar 5. Bioorg Chem. 2021. PMID: 33721808

3

Molecular Docking and Dynamics Simulation Revealed the Potential Inhibitory Activity of ACEIs Against SARS-CoV-2 Targeting the hACE2 Receptor.

Al-Karmalawy AA, Dahab MA, Metwaly AM, Elhady SS, Elkaeed EB, Eissa IH, Darwish KM. Al-Karmalawy AA, et al. Among authors: dahab ma. Front Chem. 2021 May 4;9:661230. doi: 10.3389/fchem.2021.661230. eCollection 2021. Front Chem. 2021. PMID: 34017819 Free PMC article.

4

Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.

Eissa IH, Dahab MA, Ibrahim MK, Alsaif NA, Alanazi AZ, Eissa SI, Mehany ABM, Beauchemin AM. Eissa IH, et al. Among authors: dahab ma. Bioorg Chem. 2021 Jul;112:104965. doi: 10.1016/j.bioorg.2021.104965. Epub 2021 May 5. Bioorg Chem. 2021. PMID: 34020238

5

New bis([1,2,4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: Design, synthesis, in silico studies, and anticancer evaluation.

Alanazi MM, Mahdy HA, Alsaif NA, Obaidullah AJ, Alkahtani HM, Al-Mehizia AA, Alsubaie SM, Dahab MA, Eissa IH. Alanazi MM, et al. Among authors: dahab ma. Bioorg Chem. 2021 Jul;112:104949. doi: 10.1016/j.bioorg.2021.104949. Epub 2021 Apr 30. Bioorg Chem. 2021. PMID: 34023640

6

Identification of new [1,2,4]triazolo[4,3-a]quinoxalines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, anticancer evaluation, and in silico studies.

Alsaif NA, Taghour MS, Alanazi MM, Obaidullah AJ, Alanazi WA, Alasmari A, Albassam H, Dahab MA, Mahdy HA. Alsaif NA, et al. Among authors: dahab ma. Bioorg Med Chem. 2021 Sep 15;46:116384. doi: 10.1016/j.bmc.2021.116384. Epub 2021 Aug 28. Bioorg Med Chem. 2021. PMID: 34479065

7

New benzoxazole derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, anti-proliferative evaluation, flowcytometric analysis, and in silico studies.

Elkady H, Elwan A, El-Mahdy HA, Doghish AS, Ismail A, Taghour MS, Elkaeed EB, Eissa IH, Dahab MA, Mahdy HA, Khalifa MM. Elkady H, et al. Among authors: dahab ma. J Enzyme Inhib Med Chem. 2022 Dec;37(1):397-410. doi: 10.1080/14756366.2021.2015343. J Enzyme Inhib Med Chem. 2022. PMID: 34961427 Free PMC article.

8

New quinoxaline-based VEGFR-2 inhibitors: design, synthesis, and antiproliferative evaluation with in silico docking, ADMET, toxicity, and DFT studies.

Alanazi MM, Elkady H, Alsaif NA, Obaidullah AJ, Alkahtani HM, Alanazi MM, Alharbi MA, Eissa IH, Dahab MA. Alanazi MM, et al. Among authors: dahab ma. RSC Adv. 2021 Oct 12;11(48):30315-30328. doi: 10.1039/d1ra05925d. eCollection 2021 Sep 6. RSC Adv. 2021. PMID: 35493991 Free PMC article.

9

Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers.

Eissa IH, El-Haggar R, Dahab MA, Ahmed MF, Mahdy HA, Alsantali RI, Elwan A, Masurier N, Fatahala SS. Eissa IH, et al. Among authors: dahab ma. J Enzyme Inhib Med Chem. 2022 Dec;37(1):1587-1599. doi: 10.1080/14756366.2022.2081844. J Enzyme Inhib Med Chem. 2022. PMID: 35637622 Free PMC article.

10

Benzoxazole derivatives as new VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in silico studies, and antiproliferative evaluation.

Taghour MS, Mahdy HA, Gomaa MH, Aglan A, Eldeib MG, Elwan A, Dahab MA, Elkaeed EB, Alsfouk AA, Khalifa MM, Eissa IH, Elkady H. Taghour MS, et al. Among authors: dahab ma. J Enzyme Inhib Med Chem. 2022 Dec;37(1):2063-2077. doi: 10.1080/14756366.2022.2103552. J Enzyme Inhib Med Chem. 2022. PMID: 35875937 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

28 results

Search Page

Filters